Patel, et al.. Fel D 1–derived Peptide Antigen Desensitization Shows a Persistent Treatment Effect 1 Year After the Start of Dosing: A Randomized, Placebo-controlled Study. Elsevier BV, 2013, doi:10.1016/j.jaci.2012.07.028.